Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (571-580 of 679) with videos related to

Pageof 68
Sort By:
Neuropsychopharmacology Reports|July 17, 2022
Findings of <sup>18</sup> F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sampleShogyoku Bun, Sho Moriguchi, Toshiki Tezuka, et al.
Journal of Psychiatry & Neuroscience : JPN|September 14, 2022
Reduced signal propagation elicited by frontal transcranial magnetic stimulation is associated with oligodendrocyte abnormalities in treatment-resistant depressionMasataka Wada, Shinichiro Nakajima, Shiori Honda, et al.
Plos One|September 7, 2021
Subjective well-being and month-long LF/HF ratio among deskworkersKiko Shiga, Keisuke Izumi, Kazumichi Minato, et al.
International Psychogeriatrics|June 8, 2026
From depression symptom management to dementia prevention: Considering next decade research, treatment, and advocacy priorities to reduce the impact of depression in neurocognitive disordersJordan Karp, Meryl Butters, Lucia Crivelli, et al.
Neuroscience and Biobehavioral Reviews|April 3, 2018
Kynurenine pathway in depression: A systematic review and meta-analysisKamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, et al.
JAMA Network Open|June 16, 2025
Repetitive Transcranial Magnetic Stimulation as Maintenance Treatment of Depression: The MAINT-R Randomized Clinical TrialYoshihiro Noda, Masataka Wada, Yu Mimura, et al.
Psychiatry and Clinical Neurosciences|April 12, 2024
Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese populationTomoyuki Ohara, Harutsugu Tatebe, Jun Hata, et al.
Schizophrenia Bulletin|November 17, 2023
Associations Between Structural Covariance Network and Antipsychotic Treatment Response in SchizophreniaSakiko Tsugawa, Shiori Honda, Yoshihiro Noda, et al.
Geroscience|May 18, 2026
Development of 5-year risk prediction models for incident dementia and mortality in a community-dwelling older Japanese population: The Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)Xiangyin Meng, Takanori Honda, Tomoyuki Ohara, et al.
The International Journal of Neuropsychopharmacology|October 11, 2017
Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2Sho Moriguchi, Harumasa Takano, Yasuyuki Kimura, et al.
Pageof 68

Showing results (571-580 of 679) with videos related to

Sort By:
Pageof 68
Neuropsychopharmacology Reports|July 17, 2022
Findings of <sup>18</sup> F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sampleShogyoku Bun, Sho Moriguchi, Toshiki Tezuka, et al.
Journal of Psychiatry & Neuroscience : JPN|September 14, 2022
Reduced signal propagation elicited by frontal transcranial magnetic stimulation is associated with oligodendrocyte abnormalities in treatment-resistant depressionMasataka Wada, Shinichiro Nakajima, Shiori Honda, et al.
Plos One|September 7, 2021
Subjective well-being and month-long LF/HF ratio among deskworkersKiko Shiga, Keisuke Izumi, Kazumichi Minato, et al.
International Psychogeriatrics|June 8, 2026
From depression symptom management to dementia prevention: Considering next decade research, treatment, and advocacy priorities to reduce the impact of depression in neurocognitive disordersJordan Karp, Meryl Butters, Lucia Crivelli, et al.
Neuroscience and Biobehavioral Reviews|April 3, 2018
Kynurenine pathway in depression: A systematic review and meta-analysisKamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, et al.
JAMA Network Open|June 16, 2025
Repetitive Transcranial Magnetic Stimulation as Maintenance Treatment of Depression: The MAINT-R Randomized Clinical TrialYoshihiro Noda, Masataka Wada, Yu Mimura, et al.
Psychiatry and Clinical Neurosciences|April 12, 2024
Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese populationTomoyuki Ohara, Harutsugu Tatebe, Jun Hata, et al.
Schizophrenia Bulletin|November 17, 2023
Associations Between Structural Covariance Network and Antipsychotic Treatment Response in SchizophreniaSakiko Tsugawa, Shiori Honda, Yoshihiro Noda, et al.
Geroscience|May 18, 2026
Development of 5-year risk prediction models for incident dementia and mortality in a community-dwelling older Japanese population: The Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)Xiangyin Meng, Takanori Honda, Tomoyuki Ohara, et al.
The International Journal of Neuropsychopharmacology|October 11, 2017
Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2Sho Moriguchi, Harumasa Takano, Yasuyuki Kimura, et al.
Pageof 68